The global radiotherapy market is evaluated at US$8.058 billion for the year 2019 growing at a CAGR of 8.06% reaching the market size of US$13.861 billion by the year 2026.
The global radiotherapy market growth is expected to be driven by the reduction in treatment cost, the increase in cancer cases, large-scale investments in R&D for cancer treatments, and the development of non-invasive procedures for treatment. The factors such as availability of alternative therapy, inability to be used for metastasis state of cancer, and side effects like skin rashes are likely to hinder the global radiotherapy market.
A key factor expected to be responsible for market growth is the rise in the number of cancer cases at a global level.
The demand for radiotherapy treatment increased in the United States over the years with a significant rise in the number of cancer cases. According to a report by the Centers for Disease Control & Prevention, the number of cancer cases increased from 15,74,811 in 2010 to 17,08,921 in 2018.
The advent of COVID-19 had an adverse impact on the global radiotherapy market. The immense downturn in the global radiation oncology sites is due to the widespread scare of the pandemic during the year 2020. This restricted their movements and patients preferred to stay at home to reduce exposure. Similarly, according to research by the University of Leeds, with Public Health England and the Royal College of Radiologists, reveals that there was a decrease in radiotherapy treatment courses of 19.9% in April, 6.2% in May, and 11.6% in June 2020, compared with the same months the previous year in England. The study also highlighted that the greater use of hypofractionated dosing regimens has helped radiation oncology sites deliver radiation therapy to cancer patients in England during the COVID-19 pandemic, offsetting a massive decline in treatment sessions overall. With the world recovering from the pandemic, many patients are expected to resume their treatments starting from the second quarter of 2021. This trend is expected to continue during the forecast period as well.
Asia Pacific region is expected to grow at a significant pace during the forecast period
The rise in the demand for radiotherapy treatment in the region is major because of the exponential rise in the number of cancer cases in the region. Moreover, the region contributes to more than half of all cancer cases worldwide. This indicates the increasing adoption of radiotherapy measures in order to curb the disease in the coming years.
|Market size value in 2019||US$8.058 billion|
|Market size value in 2026||US$13.861 billion|
|Growth Rate||CAGR of 8.06% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Therapy Type, Application, End-User, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Elekta AB, Accuray Incorporated, Ion Beam Applications (IBA), Isoray Medical, Inc., Canon Medical Systems Corporation, Mirada Medical, Eckert & Ziegler, Siemens Healthineers, Varian Medical Systems, Inc, Mevion Medical Systems, Inc.|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the radiotherapy market?
A1. The global radiotherapy market is projected to grow at a CAGR of 8.06% during the forecast period.
Q2. What is the size of the global radiotherapy market?
A2. Radiotherapy Market was valued at US$8.058 billion in 2019.
Q3. What will be the radiotherapy market size by 2026?
A3. The radiotherapy market is projected to reach a market size of US$13.861 billion by 2026.
Q4. What factors are anticipated to drive the radiotherapy market growth?
A4. The factors such as availability of alternative therapy, inability to be used for metastasis state of cancer, and side effects like skin rashes are likely to hinder the global radiotherapy market.
Q5. Which region holds the largest market share in the radiotherapy market?
A5. Asia Pacific region is expected to grow at a significant pace in the radiotherapy market during the forecast period.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Radiotherapy Market Analysis, by Therapy type
5.2. External Beam Radiotherapy
5.3. Internal Beam Radiotherapy/Brachytherapy
5.4. Systemic Radiotherapy
6. Radiotherapy Market Analysis, by Application
6.2. Prostate Cancer
6.3. Breast Cancer
6.4. Lung Cancer
6.5. Head And Neck Cancer
7. Radiotherapy Market Analysis, by End-user
7.3. Ambulatory Surgical Centres
8. Radiotherapy Market Analysis, by Geography
8.2. North America
8.3. South America
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.6. Asia Pacific
8.6.4. South Korea
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Elekta AB
10.2. Accuray Incorporated
10.3. Ion Beam Applications (IBA)
10.4. Isoray Medical, Inc.
10.5. Canon Medical Systems Corporation
10.6. Mirada Medical
10.7. Eckert & Ziegler
10.8. Siemens Healthineers
10.9. Varian Medical Systems, Inc
10.10. Mevion Medical Systems, Inc.
Ion Beam Applications (IBA)
Isoray Medical, Inc.
Canon Medical Systems Corporation
Eckert & Ziegler
Varian Medical Systems, Inc
Mevion Medical Systems, Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.